INTERNATIONAL BIOTECHNOLOGY TRUST PLC - Q1 2019 holdings

$271 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 62 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 55.6% .

 Value Shares↓ Weighting
CELG BuyCelgene Corp$22,214,000
+95.5%
235,522
+4.4%
8.21%
+16.4%
GILD BuyGilead Sciences Inc$18,094,000
+72.6%
278,284
+30.5%
6.68%
+2.8%
REGN BuyRegeneron Pharmaceuticals$12,985,000
+41.3%
31,630
+1.0%
4.80%
-15.9%
STML BuyStemline Therapeutics Inc$10,232,000
+134.4%
796,245
+35.9%
3.78%
+39.5%
ALXN  Alexion Pharmaceuticals Inc$9,952,000
+76.7%
73,6410.0%3.68%
+5.2%
VRTX SellVertex Pharmaceuticals Inc$9,400,000
-19.8%
51,122
-43.3%
3.47%
-52.3%
NBIX SellNeurocrine Biosciences Inc$9,128,000
+29.4%
103,600
-17.6%
3.37%
-23.0%
PTCT NewPTC Therapuetics COM$9,050,000240,493
+100.0%
3.34%
INCY SellIncyte Corp$8,728,000
-31.3%
101,500
-60.1%
3.22%
-59.1%
ALKS NewALKERMES PLC$8,502,000233,000
+100.0%
3.14%
ILMN SellILLUMINA INC$7,799,000
-1.5%
25,100
-25.3%
2.88%
-41.3%
HALO BuyHalozyme Therapeutics Inc$7,658,000
+67.2%
475,633
+19.3%
2.83%
-0.5%
ACAD SellACADIA PHARMACEUTICALS INC$7,220,000
+101.7%
269,000
-4.6%
2.67%
+20.1%
AERI BuyAerie Pharmaceuticals Inc$7,178,000
+1588.9%
151,117
+907.4%
2.65%
+904.5%
KALV SellKalvista Pharmaceuticals Inc$6,062,000
+22.4%
213,061
-33.3%
2.24%
-27.1%
ENTA BuyEnanta Pharmaceuticals Inc$5,827,000
+143.8%
61,000
+41.9%
2.15%
+45.2%
EXEL SellExelixis Inc$5,794,000
-36.4%
243,534
-58.7%
2.14%
-62.1%
BMRN SellBiomarin Pharmaceutical Inc$5,704,000
-7.6%
64,284
-30.3%
2.11%
-45.0%
WVE NewWAVE LIFE SCIENCES LTD$5,632,000145,000
+100.0%
2.08%
SAGE BuySage Therapeutics Inc$5,407,000
+349.5%
33,996
+112.5%
2.00%
+167.5%
ZGNX  Zogenix Inc$5,114,000
+92.3%
93,0000.0%1.89%
+14.5%
RTRX NewRetrophin Inc$4,703,000208,000
+100.0%
1.74%
AMGN  Amgen Inc$4,558,000
+24.2%
24,0000.0%1.68%
-26.0%
SGEN BuySeattle Genetics Inc$4,460,000
+136.0%
60,900
+43.3%
1.65%
+40.5%
IONS BuyIonis Pharmaceuticals Inc$3,877,000
+128.3%
47,781
+19.5%
1.43%
+35.9%
HZNP BuyHorizon Pharma Plc$3,382,000
+219.4%
128,000
+85.5%
1.25%
+90.1%
ABMD  Abiomed Inc$3,341,000
+11.9%
11,7000.0%1.23%
-33.4%
INSM NewINSMED INC$3,198,000110,000
+100.0%
1.18%
ALNY  Alnylam Pharmaceuticals Inc$3,160,000
+63.3%
33,8000.0%1.17%
-2.8%
SUPN BuySupernus Pharmaceuticals Inc$3,150,000
+475.9%
89,953
+329.3%
1.16%
+243.4%
XENT  Intersect Ent Inc$3,087,000
+45.4%
96,0000.0%1.14%
-13.4%
AMRN BuyAmarin Corp Plcspons adr new$2,841,000
+232.7%
137,000
+71.2%
1.05%
+98.1%
GWPH BuyGW Pharmaceuticals Plcads$2,831,000
+286.7%
16,800
+75.0%
1.05%
+130.4%
BLUE  Bluebird Bio Inc$2,675,000
+102.0%
17,0000.0%0.99%
+20.2%
AGIO  Agios Pharmaceuticals Inc$2,462,000
+86.4%
36,5000.0%0.91%
+11.0%
BIIB SellBiogen Inc$2,245,000
-44.7%
9,500
-44.8%
0.83%
-67.1%
AKCA NewAKCEA THERAPEUTICS INC$2,110,00074,608
+100.0%
0.78%
RDUS SellRadius Health Inc$2,109,000
-38.3%
105,829
-59.9%
0.78%
-63.3%
NKTR  NEKTAR THERAPEUTICS$2,016,000
+30.2%
60,0000.0%0.74%
-22.5%
ARRY  Array Biopharma Inc$1,767,000
+117.9%
72,5000.0%0.65%
+29.8%
STRO  SUTRO BIOPHARMA INC$1,670,000
+58.7%
146,6530.0%0.62%
-5.5%
SRPT SellSarepta Therapeutics Inc$1,643,000
+12.8%
13,800
-18.8%
0.61%
-32.9%
GTHX NewG1 Therapeutics Inc$1,631,00098,482
+100.0%
0.60%
ASND NewASCENDIS PHARMA A Ssponsored adr$1,624,00013,800
+100.0%
0.60%
MRTX NewMIRATI THERAPEUTICS INC$1,590,00021,700
+100.0%
0.59%
MYOK NewMyokardia INC$1,559,00030,000
+100.0%
0.58%
BHVN NewBIOHAVEN PHARMACTL HLDG CO L$1,544,00030,000
+100.0%
0.57%
GBT NewGlobal Blood Therapeutics$1,481,00028,000
+100.0%
0.55%
XLRN NewACCELERON PHARMA INC$1,396,00030,000
+100.0%
0.52%
MYGN NewMyriad Genetics inc$1,273,00038,365
+100.0%
0.47%
IFRX NewINFLARX NV$1,223,00032,500
+100.0%
0.45%
GMED  Globus Med Inc$1,196,000
+45.5%
24,2000.0%0.44%
-13.3%
FGEN  FibroGen Inc$1,071,000
+49.6%
19,7000.0%0.40%
-10.8%
MLND NewMillendo Therapeutics Inc$925,00061,860
+100.0%
0.34%
LGND SellLigand Pharmaceuticals Inc$918,000
-84.7%
7,300
-87.0%
0.34%
-90.9%
FOLD  Amicus Therapeutics Inc$796,000
+80.9%
58,6000.0%0.29%
+7.7%
MNTA NewMOMENTA PHARMACEUTICALS INC$792,00054,580
+100.0%
0.29%
TCDA NewTricida Inc$751,00019,066
+100.0%
0.28%
ARNA NewArena Pharmaceuticals Inc$740,00016,500
+100.0%
0.27%
SGMO  Sangamo Therapeutics Inc$457,000
+5.8%
48,0000.0%0.17%
-36.9%
DERM NewDermira Inc$407,00030,000
+100.0%
0.15%
MGNX NewMACROGENICS INC$342,00019,000
+100.0%
0.13%
PTLA ExitPORTOLA PHARMACEUTICALS INC$0-24,000
-100.0%
-0.23%
ONCE ExitSpark Therapeutics Inc$0-12,000
-100.0%
-0.23%
SBPH ExitSpring Bk Pharmaceuticals Inc$0-73,000
-100.0%
-0.37%
SHPG ExitShire plcsponsored adr$0-25,000
-100.0%
-2.12%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GILEAD SCIENCES INC COMMO28Q3 20239.3%
INCYTE CORP INC COM28Q3 20237.9%
BIOMARIN PHARMACEUTICALS INC28Q3 20237.5%
REGENERON PHARMS.27Q3 20239.0%
BIOGEN INC COMMON STOCK26Q3 20238.7%
VERTEX PHARMS.25Q3 20238.4%
AMGEN INC COM25Q3 20237.9%
NEUROCRINE BIOSCIENCES INC25Q3 20236.9%
ALYNYLAM PHARMACEUTICALS INC25Q3 20236.7%
IONIS PHARMS.25Q3 20234.0%

View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.

Latest significant ownerships (13-D/G)
INTERNATIONAL BIOTECHNOLOGY TRUST PLC Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Altus Pharmaceuticals Inc.February 12, 2009? ?
MICROMET, INC.February 14, 20081,907,3904.7%
EPIMMUNE INCFebruary 15, 20051,279,6598.0%
ESSENTIAL THERAPEUTICS INCApril 29, 20032,500,00011.7%
TARGETED GENETICS CORP /WA/April 18, 2003? ?
ESSENTIAL THERAPEUTICS INCNovember 05, 20011113.0%
ONYX PHARMACEUTICALS INCOctober 15, 20011113.0%
CORVAS INTERNATIONAL INCOctober 12, 20011113.0%
RIBOZYME PHARMACEUTICALS INCOctober 05, 20011113.0%

View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-08
13F-HR2023-05-18
13F-HR2023-02-01
13F-HR2022-11-08
13F-HR2022-08-16
13F-HR2022-05-20
13F-HR2022-02-15
13F-HR2021-11-12
13F-HR2021-08-11

View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (270677000.0 != 270681000.0)

Export INTERNATIONAL BIOTECHNOLOGY TRUST PLC's holdings